ARSYNL Rx Tirzepatide Review: Pricing, Care and Refund Terms

ARSYNL Rx advertises compounded tirzepatide injections at $269/month on a one-month plan labeled flexible and billed monthly. The product page describes flat pricing with medication included and no separate membership fee. A separate needle-free tirzepatide HypoSpray product is also marketed; it is not the injection reviewed here.^3,4

The useful decision is which preparation you would receive, what the selected plan charges and what happens if treatment stops. A route of administration or a lower headline is not evidence that two products deliver equivalent treatment.

Compare the product and the payment

The injection page describes weekly treatment, provider-reviewed dose increases, consultation, medication, injection supplies and free delivery. Its flat-price claim accompanies a dosing ladder from 2.5 mg through 15 mg; it does not establish the vial concentration or quantity for an individual prescription.⁴

The homepage displays a broader $269–$1,299 range for the named injection. That range does not establish a longer plan’s duration or an upfront invoice. Use the named page’s $269 monthly plan for the monthly comparison, and obtain the first charge, supply, renewal amount and any remaining obligation for the option you actually choose. A generic $199.99 GLP-1 headline is not the named tirzepatide quote.^3,4

There is also an ingredient-label discrepancy: the product breadcrumb and homepage say B12, while the current product body describes tirzepatide with B6. Confirm the actual compounded ingredients on the prescription and pharmacy label. Neither vitamin’s benefit or interchangeability is established by this review.^3,4

HypoSpray is marketed separately as a transdermal product. It should not be treated as interchangeable with the injection, or with another provider’s oral product. Obtain the prescribed route and product-specific administration instructions rather than following the instructions for a different formulation.³

From intake to ongoing care

The homepage describes a health questionnaire, clinician review and shipment, with follow-up and dose optimization advertised. These are the company’s descriptions, not a guarantee of approval, a particular response time or delivery by a promised date.³

The product page names the Arora Health provider network, including Sean Arora, MD, Shannon Arora, MD and Alex Saucedo, MD, with leadership and certification descriptions. Those are provider-reported identities and credentials, not independent verification of your assigned practitioner.⁴

The May 9, 2026 telehealth consent distinguishes ARSYNL’s coordination platform from the independent medical practices that provide care. It says provider credentials are available through the patient profile before consultation and that an in-person assessment may be recommended when remote information is insufficient. Ask who will evaluate you and how to reach that practitioner between visits.⁷

The homepage’s nationwide availability, board-certification and LegitScript language is provider-reported. It does not independently verify the assigned clinician, current treatment availability in your state or the pharmacy preparing your prescription. Confirm those details before paying.³

Cancellation, shipping and refunds

The prescription policy prohibits ordinary returns after dispensing. Its financial cutoff combines charging the payment method and handing the package to the carrier. It also describes subscription cancellation through the account before shipment. Confirm that a cancellation has been recorded and which order or renewal it affects.⁶

For damage or transit loss, the policy directs patients to support. Lost packages are addressed through location or redirection efforts and reshipment. Its separate thirty-day allowance is for unopened nonprescription items; it is not a tirzepatide return period.⁶

The product’s money-back marketing does not establish an unconditional refund. The inspected public rules do not clearly settle clinical-denial charges, an already-paid but unshipped order or unused portions of a longer commitment. Obtain those rules with the selected agreement rather than assuming either that every charge is refundable or that every cancellation forfeits it.^4,6

The returns page also makes a generic statement about not shipping refrigerated products. That does not establish the storage or transit stability of your tirzepatide preparation. Ask the dispensing pharmacy for its label instructions and a temperature-excursion plan.⁶

Cash payment and the dispensing pharmacy

The consent describes cash payment, with fees due at service, and asks for written notice of an incorrect charge within fifteen calendar days. The Terms prohibit submitting the telemedicine-service charge to public or private payors. Neither statement establishes insurance coverage for a separate medication purchase.^5,7

The Terms allow requesting a chosen pharmacy before completing the order and leave prescribing to the clinician. A requested pharmacy may have its own dispensing price and may not supply the same preparation. Confirm the actual facility, ingredients, concentration, prescription quantity and state dispensing authority; a general pharmacy or certification claim does not verify a particular vial.⁵

Evidence and our assessment

Compounded tirzepatide is not an FDA-approved finished drug. SURMOUNT-1 and SURMOUNT-5 studied approved injectable treatment, not ARSYNL’s compounded injection, added vitamins or transdermal product. Those trials do not establish equivalent absorption, safety or outcomes for these preparations.^1,2 Our compounding guide and evidence guide explain that distinction.

ARSYNL publishes named treatment options and prescription-specific cancellation boundaries. Its named monthly price and included care can be compared directly, while the ingredient-label discrepancy and unresolved financial details deserve clarification before purchase. Compare AlyveRx and the provider comparison using each program’s own formulation and agreement, without transferring benefits between routes.

Discuss risks with the treating clinician; the side-effect guide, gallbladder discussion and thyroid warning explanation can help prepare those questions.